Paper42005166
Inhibitor-Free Variant of the Cheung Regimen: Successful Adjunctive Therapy in Long-Standing Hypochondriasis With Prominent Somatic Features.
Cheung N. Cureus, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Inhibitor-Free Variant of the Cheung Regimen: Successful Adjunctive Therapy in Long-Standing Hypochondriasis With Prominent Somatic Features. Papers, record 42005166. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42005166
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Inhibitor-Free Variant of the Cheung Regimen: Successful Adjunctive Therapy in Long-Standing Hypochondriasis With Prominent Somatic Features.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References16
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4064464 | Polymorphic dextromethorphan metabolism: co-segregation of oxidative O-demethylation with debrisoquin hydroxylation. | Clin Pharmacol Ther | 1985 | https://conductscience.org/library/papers/4064464 | PubMed |
| 2 | 31566163 | Dextromethorphan/Bupropion: A Novel Oral NMDA (N-methyl-d-aspartate) Receptor Antagonist with Multimodal Activity. | CNS Spectr | 2019 | https://conductscience.org/library/papers/31566163 | PubMed |
| 3 | 41924710 | DXM, CYP2D6-inhibiting antidepressants, piracetam, and glutamine: proposing a ketamine-class antidepressant regimen with existing drugs. | Front Psychiatry | 2026 | https://conductscience.org/library/papers/41924710 | PubMed |
| 4 | 25804358 | Involvement of AMPA receptors in the antidepressant-like effects of dextromethorphan in mice. | Behav Brain Res | 2015 | https://conductscience.org/library/papers/25804358 | PubMed |
| 5 | 36353484 | Physiologically based pharmacokinetic (PBPK) modeling of the role of CYP2D6 polymorphism for metabolic phenotyping with dextromethorphan. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/36353484 | PubMed |
| 6 | 23284146 | Hypochondriasis and health anxiety: conceptual challenges. | Br J Psychiatry | 2013 | https://conductscience.org/library/papers/23284146 | PubMed |
| 7 | 23783065 | Randomized controlled crossover trial of ketamine in obsessive-compulsive disorder: proof-of-concept. | Neuropsychopharmacology | 2013 | https://conductscience.org/library/papers/23783065 | PubMed |
| 8 | 16717171 | A brief measure for assessing generalized anxiety disorder: the GAD-7. | Arch Intern Med | 2006 | https://conductscience.org/library/papers/16717171 | PubMed |
| 9 | 2787473 | Oxidation of midazolam and triazolam by human liver cytochrome P450IIIA4. | Mol Pharmacol | 1989 | https://conductscience.org/library/papers/2787473 | PubMed |
| 10 | 20163115 | Piracetam defines a new binding site for allosteric modulators of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) receptors. | J Med Chem | 2010 | https://conductscience.org/library/papers/20163115 | PubMed |
| 11 | 15784664 | The serotonin syndrome. | N Engl J Med | 2005 | https://conductscience.org/library/papers/15784664 | PubMed |
| 12 | 19616195 | Cognitive behavioral therapy versus paroxetine in the treatment of hypochondriasis: an 18-month naturalistic follow-up. | J Behav Ther Exp Psychiatry | 2009 | https://conductscience.org/library/papers/19616195 | PubMed |
| 13 | 35582785 | Effect of AXS-05 (Dextromethorphan-Bupropion) in Major Depressive Disorder: A Randomized Double-Blind Controlled Trial. | Am J Psychiatry | 2022 | https://conductscience.org/library/papers/35582785 | PubMed |
| 14 | 1372342 | Nootropic drugs positively modulate alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-sensitive glutamate receptors in neuronal cultures. | J Neurochem | 1992 | https://conductscience.org/library/papers/1372342 | PubMed |
| 15 | 26301176 | Glutamatergic agents for OCD and related disorders. | Curr Treat Options Psychiatry | 2015 | https://conductscience.org/library/papers/26301176 | PubMed |
| 16 | 11556941 | The PHQ-9: validity of a brief depression severity measure. | J Gen Intern Med | 2001 | https://conductscience.org/library/papers/11556941 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CYP2D6 | 1565 | PubTator's text mining | https://conductscience.org/library/genes/1565 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42005166
GET https://conductscience.org/api/papers/v1/42005166/authors